PharmaCentral

Tag: CYP2C19

Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects

Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects
  • Dylan Coronado
  • Dylan Coronado

19/02
8

Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.

Read More...

Categories

  • Health (118)
  • Pharmacy (60)

Popular Articles

Are Natural Products Safer Than Pharmaceuticals? The Real Risks of Supplement Interactions
Are Natural Products Safer Than Pharmaceuticals? The Real Risks of Supplement Interactions

Nov 19 2025

Antibiotic Stewardship: How to Prevent Resistance and Protect Your Gut Health
Antibiotic Stewardship: How to Prevent Resistance and Protect Your Gut Health

Mar 18 2026

Measuring Education Effectiveness: Tracking Generic Understanding in Patient Care
Measuring Education Effectiveness: Tracking Generic Understanding in Patient Care

Dec 4 2025

Pricing Pressure and Shortages: How Drug Manufacturers Are Under Financial Siege
Pricing Pressure and Shortages: How Drug Manufacturers Are Under Financial Siege

Feb 28 2026

Generic Appearance Changes: Why Your Pill Color and Shape Keep Changing
Generic Appearance Changes: Why Your Pill Color and Shape Keep Changing

Nov 28 2025

Tags

  • side effects
  • online pharmacy
  • drug interactions
  • generic drugs
  • mental health
  • blood thinners
  • drug side effects
  • drug safety
  • SSRIs
  • bioequivalence
  • erectile dysfunction
  • clinical trials
  • DOACs
  • warfarin alternatives
  • beta-blockers
  • kidney disease
  • phosphate binders
  • Sildenafil
  • adverse drug reactions
  • polypharmacy
PharmaCentral

Menu

  • About Us
  • Terms of Service
  • Privacy Policy
  • Data Protection Overview
  • Contact Us

© 2026. All rights reserved.